1. Home
  2. LIDRW vs HUMAW Comparison

LIDRW vs HUMAW Comparison

Compare LIDRW & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AEye Inc. Warrant

LIDRW

AEye Inc. Warrant

HOLD

Current Price

$0.02

Market Cap

0.0

ML Signal

HOLD

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

HOLD

Current Price

$0.11

Market Cap

0.0

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIDRW
HUMAW
Founded
N/A
2004
Country
United States
United States
Employees
45
184
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
LIDRW
HUMAW
Price
$0.02
$0.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
50.0K
17.9K
Earning Date
N/A
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.03
$0.08
52 Week High
$0.58
$0.60

Technical Indicators

Market Signals
Indicator
LIDRW
HUMAW
Relative Strength Index (RSI) 39.18 54.89
Support Level N/A $0.09
Resistance Level $0.12 $0.12
Average True Range (ATR) 0.01 0.01
MACD -0.00 0.00
Stochastic Oscillator 0.32 70.18

Price Performance

Historical Comparison
LIDRW
HUMAW

About LIDRW AEye Inc. Warrant

AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: